SCHEMBL20448792

SCHEMBL20448792

CCOC(=O)c1nnc(N2CC[C@@H](NC(=O)c3nc(Cl)c(CC)[nH]3)[C@@H](OC)C2)s1

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ABCC2 Q92887 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20448851 0.94 ABCC2 (0.39) ABCC2
SCHEMBL20448786 0.92 ABCC2 (0.46) ABCC2
SCHEMBL20448805 0.90 ABCC2 (0.43) ABCC2
SCHEMBL20448796 0.90 ABCC2 (0.45) ABCC2
SCHEMBL2846461 0.88 ABCC2 (0.48) ABCC2
SCHEMBL2845361 0.88 ABCC2 (0.48) ABCC2
SCHEMBL2823954 0.88 ABCC2 (0.48) ABCC2
SCHEMBL13787547 0.88 ABCC2 (0.48) ABCC2
SCHEMBL2845363 0.88 ABCC2 (0.48) ABCC2
SCHEMBL2850137 0.87 ABCC2 (0.48) ABCC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108137574-B Hydroxyalkyl thiadiazole derivatives 第一三共株式会社 2021-12-28 CN disclosed
US-10752647-B2 N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-08-25 US disclosed
EP-3356361-B1 HYDROXYALKYL THIADIAZOLE DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2020-07-08 EP disclosed
US-20200040019-A1 N-PHOSPHONOXYMETHL PRODRUGS OF HYDROXYALKYL THIADIAZOLE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-02-06 US disclosed
US-10399968-B2 Hydroxyalkyl thiadiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2019-09-03 US disclosed
US-20180327399-A1 HYDROXYALKYL THIADIAZOLE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2018-11-15 US disclosed
WO-2018169092-A1 N-PHOSPHONOXYMETHYL PRODRUGS OF HYDROXYALKYL THIADIAZOLE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2018-09-20 WO disclosed
EP-3356361-A1 HYDROXYALKYL THIADIAZOLE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2018-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10399968-B2 Hydroxyalkyl thiadiazole derivatives TOP1, TOP2B, TOP2A ABCC2 2306/4885
US-10752647-B2 N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives PHYKPL, SLC34A1, PNKP ABCC2 2194/4885
US-20200040019-A1 N-PHOSPHONOXYMETHL PRODRUGS OF HYDROXYALKYL THIADIAZOLE DERIVATIVES PHYKPL, SLC34A1, PNKP ABCC2 1943/4885
US-20180327399-A1 HYDROXYALKYL THIADIAZOLE DERIVATIVES TOP1, TOP2B, TOP2A ABCC2 2306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.